Illinois Cancer Specialists

Industry News

Complication rates reduced by new method to restore skull after brain surgery

Feb 05, 2014

Johns Hopkins surgeons report they have devised a better, safer method to replace bone removed from the skull after lifesaving brain surgery. The new technique, they say, appears to result in fewer complications than standard restoration, which has changed little since its development in the 1890s. Read More

Genetic function discovered that could offer new avenue to cancer therapies

Feb 05, 2014

Researchers at Oregon State University have discovered a genetic function that helps one of the most important "tumor suppressor" genes to do its job and prevent cancer.Finding ways to maintain or increase the effectiveness of this gene - called Grp1-associated scaffold protein, or Grasp - could offer an important new avenue for human cancer therapies, scientists said. Read More

IDH1 mutation determines best treatment for malignant astrocytomas

Feb 05, 2014

Astrocytomas are the most common malignant brain tumors. While most patients' tumors prove to be quite aggressive, outcomes overall can vary widely, with some patients surviving for many years. Now a new study has found that malignant astrocytoma patients whose tumors carry a specific genetic mutation benefit greatly from surgical removal of the largest possible amount of tumor. Read More

Experts publish recommendations for managing and preventing drug shortages

Feb 05, 2014

A group of prominent healthcare experts including bioethicists, pharmacists, policymakers and cancer specialists have proposed concrete steps for preventing and managing a nightmare scenario that is becoming all too common: shortages of life-saving drugs. Read More

Improved understanding of cancer offered by cell division finding

Feb 05, 2014

New insights into how the cells in our bodies divide could improve our knowledge of a condition linked to cancer, a study suggests.Errors in the cell division process - which allows us to grow and stay healthy - can lead to a genetic disorder called aneuploidy, which is also associated with birth defects and infertility. Read More

Treatment response for acute myeloid leukemia predicted by chemical stem cell signature

Feb 05, 2014

Researchers at Albert Einstein College of Medicine of Yeshiva University and Montefiore Medical Center have found a chemical "signature" in blood-forming stem cells that predicts whether patients with acute myeloid leukemia (AML) will respond to chemotherapy.The findings are based on data from nearly 700 AML patients. Read More

Treatment response for acute myeloid leukemia predicted by chemical stem cell signature

Feb 05, 2014

'Mammograms every 2 years, not annually,' suggest scientists

Feb 04, 2014

In 2009, the US Preventive Services Task Force created guidelines recommending biennial mammography screening for women between the ages of 50 and 74. And now, scientists suggest that following this guideline would be equally effective and save the US health care system $4.3 billion a year.The researchers, led by Dr. Laura J. Read More

WHO: cancer growing at 'alarming pace'

Feb 04, 2014

A new report from the World Health Organization's cancer agency reveals that cancer rates are growing at an "alarming pace" around the world and urges stronger efforts on prevention measures to curb the disease. Read More

Eisai's Phase III lenvatinib Study 303 for improvement in refractory differentiated thyroid cancer

Feb 04, 2014

Eisai has announced that the Phase III SELECT trial (Study 303) of lenvatinib, an investigational selective tyrosine kinase inhibitor (TKI) with a novel binding mode,[1] met its primary endpoint. Compared to placebo, lenvatinib showed a highly statistically significant improvement in progression free survival (PFS) in patients with radioiodine-refractory differentiated thyroid cancer (RR-DTC). Read More

Previous Page Next Page